NCT07142005
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +11 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Medullary Thyroid Cancer (MTC)
Explore clinical trials studying Medullary Thyroid Cancer (MTC). Study availability and eligibility vary by location and protocol.
5 public trials
1 recruiting study
Medullary Thyroid Cancer (MTC) trial results
Not Yet Recruiting
A Prospective Cohort Study of Pralsetinib or Anlotinib in the Treatment of Locally Advanced and/or Metastatic Medullary Thyroid Carcinoma With RET Gene Mutations
NCT07048964
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
Not specified
NCT01856920
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- NIH Clinical Center Bethesda, Maryland, United States
NCT03072160
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Completed
Nintedanib(BIBF1120) in Thyroid Cancer
NCT01788982
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +17 more
- Locations
-
- A.Z. St. Jan Bruges, Belgium
- Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
- Cliniques Universitaires Saint-Luc Brussels, Belgium
- Universitair Ziekenhuis Antwerpen Edegem, Antwerpen, Belgium